Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386740962> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W4386740962 endingPage "1154" @default.
- W4386740962 startingPage "1154" @default.
- W4386740962 abstract "<ns4:p><ns4:bold>Purpose:</ns4:bold> To report the ocular surface and meibomian gland changes in polycystic ovarian syndrome (PCOS) women taking hormone supplementation.</ns4:p><ns4:p> </ns4:p><ns4:p> <ns4:bold>Methods:</ns4:bold> Case series.</ns4:p><ns4:p> </ns4:p><ns4:p> <ns4:bold>Results:</ns4:bold> Three women (27 ± 11 years) already diagnosed with PCOS presented with dry eye symptoms (mean OSDI, 37.5) for a mean duration of 13 months and were taking hormonal supplements for a mean duration of 60 ± 11 months. The hormonal supplements included oral estrogen (n=3), oral progesterone (n=3), antiandrogen cyproterone (n=1) and isotretinoin (n=1). Ocular surface evaluation revealed mean NIBUT of 9.9 ± 1.6 seconds and mean TMH of 0.27<ns4:bold> </ns4:bold>± 0.05 mm assessed non-invasively using Oculus keratograph 5M (K5M). Meibography (K5M) showed near total loss of all meibomian glands (n=8/12 eyelids) with residual ghost glands in all four eyelids of two patients, and gland shortening alone in one eyelid. The gland morphology did not change following intense thermal pulsation treatment or cessation of hormonal therapy.</ns4:p><ns4:p> </ns4:p><ns4:p> <ns4:bold>Conclusions:</ns4:bold> Near-total irreversible meibomian gland loss was seen in two young PCOS women taking hormonal supplements. Collaboration between ophthalmologists and gynecologists is advisable for early detection and better understanding of dry eye disease (DED) progression in these patients.</ns4:p>" @default.
- W4386740962 created "2023-09-15" @default.
- W4386740962 creator A5022038990 @default.
- W4386740962 creator A5063365061 @default.
- W4386740962 creator A5092871178 @default.
- W4386740962 date "2023-09-14" @default.
- W4386740962 modified "2023-09-26" @default.
- W4386740962 title "Case Series: Severe meibomian gland loss in polycystic ovarian syndrome patients on estrogen-progesterone therapy" @default.
- W4386740962 cites W1985665389 @default.
- W4386740962 cites W2027485381 @default.
- W4386740962 cites W2060893621 @default.
- W4386740962 cites W2103495514 @default.
- W4386740962 cites W2545221409 @default.
- W4386740962 cites W2895713441 @default.
- W4386740962 cites W3029111319 @default.
- W4386740962 cites W3033951898 @default.
- W4386740962 cites W4289778712 @default.
- W4386740962 cites W4294193240 @default.
- W4386740962 doi "https://doi.org/10.12688/f1000research.139229.1" @default.
- W4386740962 hasPublicationYear "2023" @default.
- W4386740962 type Work @default.
- W4386740962 citedByCount "0" @default.
- W4386740962 crossrefType "journal-article" @default.
- W4386740962 hasAuthorship W4386740962A5022038990 @default.
- W4386740962 hasAuthorship W4386740962A5063365061 @default.
- W4386740962 hasAuthorship W4386740962A5092871178 @default.
- W4386740962 hasBestOaLocation W43867409621 @default.
- W4386740962 hasConcept C118487528 @default.
- W4386740962 hasConcept C134018914 @default.
- W4386740962 hasConcept C2777164284 @default.
- W4386740962 hasConcept C2777165675 @default.
- W4386740962 hasConcept C2781302119 @default.
- W4386740962 hasConcept C42407357 @default.
- W4386740962 hasConcept C71924100 @default.
- W4386740962 hasConcept C86803240 @default.
- W4386740962 hasConceptScore W4386740962C118487528 @default.
- W4386740962 hasConceptScore W4386740962C134018914 @default.
- W4386740962 hasConceptScore W4386740962C2777164284 @default.
- W4386740962 hasConceptScore W4386740962C2777165675 @default.
- W4386740962 hasConceptScore W4386740962C2781302119 @default.
- W4386740962 hasConceptScore W4386740962C42407357 @default.
- W4386740962 hasConceptScore W4386740962C71924100 @default.
- W4386740962 hasConceptScore W4386740962C86803240 @default.
- W4386740962 hasFunder F4320323449 @default.
- W4386740962 hasLocation W43867409621 @default.
- W4386740962 hasOpenAccess W4386740962 @default.
- W4386740962 hasPrimaryLocation W43867409621 @default.
- W4386740962 hasRelatedWork W1009860394 @default.
- W4386740962 hasRelatedWork W1014442996 @default.
- W4386740962 hasRelatedWork W1820080715 @default.
- W4386740962 hasRelatedWork W1966088460 @default.
- W4386740962 hasRelatedWork W1986805757 @default.
- W4386740962 hasRelatedWork W2075096178 @default.
- W4386740962 hasRelatedWork W2079315104 @default.
- W4386740962 hasRelatedWork W2583848553 @default.
- W4386740962 hasRelatedWork W2974279124 @default.
- W4386740962 hasRelatedWork W987941184 @default.
- W4386740962 hasVolume "12" @default.
- W4386740962 isParatext "false" @default.
- W4386740962 isRetracted "false" @default.
- W4386740962 workType "article" @default.